Dengue vaccination proves effective
13:56, 2014/11/04
A dengue vaccination trial conducted by France’s Sanofi Pasteur in five Asian countries, including Vietnam, showed the efficacy in 56.5 percent of dengue-infected cases.
The vaccination also prevented 67 percent of the sufferers from being hospitalized, heard a conference reviewing the efficacy of the vaccination in the community in Ho Chi Minh City on November 3.
The trial was undertaken on 10,275 children and teenagers aged 2 to 14 in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
In Vietnam, from September 2011, 2,336 children in the two Mekong Delta provinces of An Giang and Tien Giang got vaccinated.
At the conference, director of the Health Ministry’s Preventive Medicine Department Tran Dac Phu noted that a lack of dengue vaccine is a huge burden on not only Vietnam but many other countries.
The dengue vaccine research programme has been conducted by Sanofi Pasteur over the past 20 years, with the participation of Ho Chi Minh City’s Pasteur Institute. It will be implemented until November 2017.
According to the World Health Organisation, each year, an estimated 50 million people contract dengue, of whom 500,000 require hospitalization and 25,000 die.
Sanofi Pasteur, the vaccines division of Sanofi, provides more than one billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe.
A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases.
In Vietnam, from September 2011, 2,336 children in the two Mekong Delta provinces of An Giang and Tien Giang got vaccinated.
At the conference, director of the Health Ministry’s Preventive Medicine Department Tran Dac Phu noted that a lack of dengue vaccine is a huge burden on not only Vietnam but many other countries.
The dengue vaccine research programme has been conducted by Sanofi Pasteur over the past 20 years, with the participation of Ho Chi Minh City’s Pasteur Institute. It will be implemented until November 2017.
According to the World Health Organisation, each year, an estimated 50 million people contract dengue, of whom 500,000 require hospitalization and 25,000 die.
Sanofi Pasteur, the vaccines division of Sanofi, provides more than one billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe.
A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases.
07:12, 2024/11/12
2024 International Youth Festival attracts 3,000 local and international youth
The 2024 International Youth Festival helped Hanoi’s youth connect and promote the city's culture and tourism to international friends.
21:50, 2024/11/11
Hanoi launches pilot project to integrate electronic health records into VNeID app
The system allows citizens to conveniently manage their medical histories and provides medical professionals with up-to-date information anytime, anywhere.
19:23, 2024/11/07
Empowering new generation of biodiversity champions in Vietnam
These EU-supported events provide a platform to showcase successful sustainability initiatives and inspire additional green actions.
18:52, 2024/11/04
Capital Law to make Hanoi major center for quality education
Hanoi is a hub for talent from all over the country.
16:29, 2024/11/01
Hanoi raises road safety awareness among students
The Hanoi authorities have stepped up communication to heighten the sense of responsibility of families and schools in maintaining road safety.
14:55, 2024/10/21
Hanoi pilots artificial intelligence in five schools
From kindergarten to high school, the project aims to boost digital transformation in Hanoi's education system.